Anti-CD138 chimeric antigen receptor-modified T cell therapy for multiple myeloma with extensive extramedullary involvement

被引:25
|
作者
Tian, Chen [1 ]
Yang, Hongliang [1 ]
Zhu, Lei [1 ]
Zhang, Qing [1 ]
Cao, Zeng [1 ]
Zhang, Yizhuo [1 ]
机构
[1] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1007/s00277-017-3029-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1407 / 1410
页数:4
相关论文
共 50 条
  • [1] Anti-CD138 chimeric antigen receptor-modified T cell therapy for multiple myeloma with extensive extramedullary involvement
    Chen Tian
    Hongliang Yang
    Lei Zhu
    Qing Zhang
    Zeng Cao
    Yizhuo Zhang
    Annals of Hematology, 2017, 96 : 1407 - 1410
  • [2] Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen
    Timmers, Marijke
    Roex, Gils
    Wang, Yuedi
    Campillo-Davo, Diana
    Van Tendeloo, Viggo F., I
    Chu, Yiwei
    Berneman, Zwi N.
    Luo, Feifei
    Van Acker, Heleen H.
    Anguille, Sebastien
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [3] Effective Treatment of Relapsed/Refractory Multiple Myeloma Including Extramedullary Involvement By BCMA-Specific Chimeric Antigen Receptor-Modified T Cells
    Mi, Jian-Qing
    Fan, Xiaohu
    Xu, Jie
    Liu, Yuanfang
    Zhuang, Yan
    Yang, Shuangshuang
    Zhang, Wu
    Chen, Bing
    Wang, Yueying
    Weng, Xiangqin
    Li, Junmin
    Fu, Weijun
    Jiang, Hua
    Zhu, Li
    Chen, Zhu
    Chen, Sai-Juan
    Hou, Jian
    BLOOD, 2017, 130
  • [4] Chimeric antigen receptor T cell therapy for multiple myeloma
    Kana Hasegawa
    Naoki Hosen
    Inflammation and Regeneration, 39
  • [5] Chimeric antigen receptor T cell therapy for multiple myeloma
    Hasegawa, Kana
    Hosen, Naoki
    INFLAMMATION AND REGENERATION, 2019, 39 (1)
  • [6] Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
    Yanyu Pang
    Xiaoyang Hou
    Chunsheng Yang
    Yanqun Liu
    Guan Jiang
    Molecular Cancer, 17
  • [7] Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors
    Zhang, Erhao
    Gu, Jieyi
    Xu, Hanmei
    MOLECULAR CANCER, 2018, 17
  • [8] Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
    Pang, Yanyu
    Hou, Xiaoyang
    Yang, Chunsheng
    Liu, Yanqun
    Jiang, Guan
    MOLECULAR CANCER, 2018, 17
  • [9] Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
    Zou, Yixin
    Xu, Wei
    Li, Jianyong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [10] Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
    Yixin Zou
    Wei Xu
    Jianyong Li
    Journal of Hematology & Oncology, 11